Literature DB >> 20697009

Optic nerve regeneration.

Larry I Benowitz1, Yuqin Yin.   

Abstract

Retinal ganglion cells are usually not able to regenerate their axons after optic nerve injury or degenerative disorders, resulting in lifelong visual loss. This situation can be partially reversed by activating the intrinsic growth state of retinal ganglion cells, maintaining their viability, and counteracting inhibitory signals in the extracellular environment. Advances during the past few years continue to extend the amount of regeneration that can be achieved in animal models. These findings give hope that clinically meaningful regeneration may become a reality within a few years if regenerating axons can be guided to their appropriate destinations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20697009      PMCID: PMC3072887          DOI: 10.1001/archophthalmol.2010.152

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  90 in total

Review 1.  False resurrections: distinguishing regenerated from spared axons in the injured central nervous system.

Authors:  Oswald Steward; Binhai Zheng; Marc Tessier-Lavigne
Journal:  J Comp Neurol       Date:  2003-04-21       Impact factor: 3.215

2.  Intraocular elevation of cyclic AMP potentiates ciliary neurotrophic factor-induced regeneration of adult rat retinal ganglion cell axons.

Authors:  Qi Cui; Henry K Yip; Robert C H Zhao; Kwok-Fai So; Alan R Harvey
Journal:  Mol Cell Neurosci       Date:  2003-01       Impact factor: 4.314

3.  Effect of lens lesion on neurite outgrowth of retinal ganglion cells in vitro.

Authors:  Barbara Lorber; Martin Berry; Ann Logan; David Tonge
Journal:  Mol Cell Neurosci       Date:  2002-10       Impact factor: 4.314

Review 4.  Regeneration beyond the glial scar.

Authors:  Jerry Silver; Jared H Miller
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

5.  Contribution of caspase-8 to apoptosis of axotomized rat retinal ganglion cells in vivo.

Authors:  J H Weishaupt; R Diem; P Kermer; S Krajewski; J C Reed; M Bähr
Journal:  Neurobiol Dis       Date:  2003-07       Impact factor: 5.996

Review 6.  Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS.

Authors:  Marie T Filbin
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

7.  Conversion of neuronal growth cone responses from repulsion to attraction by cyclic nucleotides.

Authors:  H Song; G Ming; Z He; M Lehmann; L McKerracher; M Tessier-Lavigne; M Poo
Journal:  Science       Date:  1998-09-04       Impact factor: 47.728

8.  Fibroblast growth factor-2 gene delivery stimulates axon growth by adult retinal ganglion cells after acute optic nerve injury.

Authors:  Przemyslaw S Sapieha; Martin Peltier; Katherine G Rendahl; William C Manning; Adriana Di Polo
Journal:  Mol Cell Neurosci       Date:  2003-11       Impact factor: 4.314

9.  Axon regeneration in goldfish and rat retinal ganglion cells: differential responsiveness to carbohydrates and cAMP.

Authors:  Yiming Li; Nina Irwin; Yuqin Yin; Marc Lanser; Larry I Benowitz
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

10.  Macrophage-derived factors stimulate optic nerve regeneration.

Authors:  Yuqin Yin; Qi Cui; Yiming Li; Nina Irwin; Dietmar Fischer; Alan R Harvey; Larry I Benowitz
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

View more
  24 in total

1.  A Self-Assembling Injectable Biomimetic Microenvironment Encourages Retinal Ganglion Cell Axon Extension in Vitro.

Authors:  Melissa R Laughter; David A Ammar; James R Bardill; Brisa Pena; Malik Y Kahook; David J Lee; Daewon Park
Journal:  ACS Appl Mater Interfaces       Date:  2016-08-02       Impact factor: 9.229

2.  Full-length axon regeneration in the adult mouse optic nerve and partial recovery of simple visual behaviors.

Authors:  Silmara de Lima; Yoshiki Koriyama; Takuji Kurimoto; Julia Teixeira Oliveira; Yuqin Yin; Yiqing Li; Hui-Ya Gilbert; Michela Fagiolini; Ana Maria Blanco Martinez; Larry Benowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

Review 3.  Positioning patients for spine surgery: Avoiding uncommon position-related complications.

Authors:  Ihab Kamel; Rodger Barnette
Journal:  World J Orthop       Date:  2014-09-18

Review 4.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions.

Authors:  Kimberly K Gokoffski; Micalla Peng; Basheer Alas; Phillip Lam
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

5.  Randomized Controlled Phase 2a Study of RPh201 in Previous Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Eitan Z Rath; Zadik Hazan; Konstantin Adamsky; Arieh Solomon; Zvi I Segal; Leonard A Levin
Journal:  J Neuroophthalmol       Date:  2019-09       Impact factor: 3.042

6.  Hyperactivated Stat3 boosts axon regeneration in the CNS.

Authors:  Saloni T Mehta; Xueting Luo; Kevin K Park; John L Bixby; Vance P Lemmon
Journal:  Exp Neurol       Date:  2016-04-06       Impact factor: 5.330

7.  Abrogation of β-catenin signaling in oligodendrocyte precursor cells reduces glial scarring and promotes axon regeneration after CNS injury.

Authors:  Justin P Rodriguez; Michael Coulter; Jill Miotke; Ronald L Meyer; Ken-Ichi Takemaru; Joel M Levine
Journal:  J Neurosci       Date:  2014-07-30       Impact factor: 6.167

8.  In vitro bioassay model for screening non-viral neurotrophic factor gene delivery systems for glaucoma treatment.

Authors:  Ding Wen Chen; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 9.  Nanotechnology-novel therapeutics for CNS disorders.

Authors:  Maya Srikanth; John A Kessler
Journal:  Nat Rev Neurol       Date:  2012-04-24       Impact factor: 42.937

10.  The effect of glial fibrillary acidic protein expression on neurite outgrowth from retinal explants in a permissive environment.

Authors:  Kimberly A Toops; Tracy L Hagemann; Albee Messing; Robert W Nickells
Journal:  BMC Res Notes       Date:  2012-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.